Leukemia Clinical Trials in Houston

Showing 581-600 of 1,657 trials

Open-Label Surufatinib in European Patients With NET

NCT04579679

This is a Phase 2, open-label, multi-centre study of surufatinib in patients with low to intermediate grade (Grade 1 or Grade 2), well-differentiated neuroendocrine tumours (NETs).

Neuroendocrine TumoursNeuroendocrine Tumour of the LungSmall Intestinal NET

Hutchmed78 participantsStarted Aug 2021

Birmingham, Alabama, United States • Orange, California, United States • Atlanta, Georgia, United States +20 more locations

Active Not RecruitingPhase 1< 1 mile

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

NCT04511845

Phase I, open-label, multi-center study

Locally Advanced or Metastatic Solid Tumors

Chugai Pharmaceutical113 participantsStarted Sep 2020

Tucson, Arizona, United States • Lone Tree, Colorado, United States • Minneapolis, Minnesota, United States +12 more locations

Open-Label Surufatinib in European Patients With NET

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Leukemia Trials in Other Cities

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

A Study to Investigate LYL797 in Adults With Solid Tumors

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Other Conditions in Houston